Trending
- Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
- AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
- Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
- WestGene’s mRNA Therapeutic Cancer Vaccine Receives FDA Approval
- Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for oligonucleotides
- Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
- Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
- Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
- Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
- BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million
Top Headlines
Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of…
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License…
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop…
Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol…
Nabla Bio, pioneers in generative protein design, announced the close of a $26 million Series A financing, led by…
WestGene’s mRNA Therapeutic Cancer Vaccine Receives FDA Approval
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval…
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for…
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization…
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License…
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. announced the companies have completed an exclusive worldwide…
Featured Event
Clinical Trials
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration…
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the…
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to…
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically…
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic…
PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the…
Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study…
Johnson & Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia…
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
Repare Therapeutics Inc. announced that, under its worldwide license and collaboration agreement with Roche for the development and commercialization…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Drug Research
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License…
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop…
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific…
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and…
FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of…
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…
Bayer and Recursion focus research collaboration on Oncology
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to…
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision…
Prelude Therapeutics Incorporated and AbCellera announced a multi-year, multi-program partnership to discover,…
Manufacturing
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for…
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization…
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of…
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that…
Astraveus awarded €10.4 million grant by the French government as part of France 2030…
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)…
Samsung Biologics and Kurma Partners announce strategic partnership for development and…
Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of…
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of…
Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind…
MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO…
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee,…
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art…
GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped…
Diseases
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation…
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to…
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral…
Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose…
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss…
Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to…
Ionis enters collaboration to advance next generation program targeting Lp(a) for…
Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for…
FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of…
Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration…
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First…
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a…